00209 Risk for disturbed maternal-fetal dyad

00209 Risk for disturbed maternal-fetal dyad

Definition of the NANDA label

Risk of alteration of the maternal-fetal symbiotic dyad as a result of comorbidity or conditions related to pregnancy.

Susceptible to a disruption of the symbiotic mother-fetal relationship as a result of comorbid or pregnancy-related conditions, which may compromise health.

Risk factors

• Pregnancy complications (eg, premature rupture of membranes, placenta previa or placental abruption, delay in prenatal care, multiple gestation).
• O2 transport compromise (eg, anemia, heart disease, asthma, hypertension, seizures, preterm labor, hemorrhage).
• Impaired glucose metabolism (eg, diabetes, steroid use).
• Physical abuse.
• Substance abuse (eg, tobacco, alcohol, drugs).
• Treatment-related side effects (eg, drugs, surgery, chemotherapy).

Associated condition

• Alteration in glucose metabolism
• Compromised fetal oxygen transport
• Pregnancy complication
• Treatment regimen


• Family environment: internal.
• Safety behavior: physical environment of the home.
• Child development.
• Execution of the role.
• Family functions.
• Father-son emotional ties.
• Be dad.
• Social support.
• Overcoming family problems.


• Environmental management: safety.
• Surveillance: security.
• Parental education.
• Stimulation of family integrity.
• Promotion of fatherhood.
• Promotion of child development: infant.
• Role empowerment.
• Infant care.
• Promotion of rapprochement.
• Promotion of development.
• Identification of risks.
• Increase in support systems.
• Increase in family involvement.